Potential of pectin for biomedical applications: a comprehensive review
Source abstract
Abstract
Pectin is a polysaccharide extracted from various plants, such as apples, oranges, lemons, and it possesses some beneficial effects on human health, including being hypoglycemic and hypocholesterolemic. Therefore, pectin is used in various pharmaceutical and biomedical applications. Meanwhile, its low mechanical strength and fast degradation rate limit its usage as drug delivery devices and tissue engineering scaffolds. To enhance these properties, it can be modified or combined with other organic molecules or polymers and/or inorganic compounds. These materials can be prepared as nano sized drug carriers in the form of spheres, capsules, hydrogels, self assamled micelles, etc., for treatment purposes (mostly cancer). Different composites or blends of pectin can also be produced as membranes, sponges, hydrogels, or 3D printed matrices for tissue regeneration applications. This review is concentrated on the properties of pectin based materials and focus especially on the utilization of these materials as drug carriers and tissue engineering scaffolds, including 3D printed and 3D bioprinted systems covering the studies in the last decade and especially in the last 5 years.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polysaccharides and Plant Cell Walls · Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biotechnology, Middle East Technical University (METU), Ankara, Turkey
Center of Excellence in Biomaterials and Tissue Engineering, METU BIOMATEN, Ankara, Turkey
Department of Chemistry, METU, Ankara, Turkey
Tissue Engineering and Biomaterial Research Center, Near East University, (NEU), Lefkosa, Turkey
Department of Engineering Sciences, METU, Ankara, Turkey
References (100+)
Show source-provided references
1. Kim MS · J Mar Biosci Biotechnol · 2021 · 13 · 28
2. Zhang S · Crit Rev Food Sci Nutr · 2021 · 1
3. 10.3390/molecules2304094210.3390/molecules23040942 ↗
4. 10.1016/j.carbpol.2017.03.05810.1016/j.carbpol.2017.03.058 ↗
5. 10.1016/j.foodhyd.2016.08.01510.1016/j.foodhyd.2016.08.015 ↗
6. 10.1016/j.tifs.2013.01.00610.1016/j.tifs.2013.01.006 ↗
7. 10.1080/1094291060092125810.1080/10942910600921258 ↗
8. 10.3390/polym1012140710.3390/polym10121407 ↗
9. 10.1016/j.ijbiomac.2012.07.00210.1016/j.ijbiomac.2012.07.002 ↗
10. 10.1016/j.ijbiomac.2017.03.02910.1016/j.ijbiomac.2017.03.029 ↗
11. 10.1093/mp/ssp06610.1093/mp/ssp066 ↗
12. 10.3390/polym1111183710.3390/polym11111837 ↗
13. 10.1016/j.carbpol.2020.11638910.1016/j.carbpol.2020.116389 ↗
14. 10.1080/87559129.2020.173300810.1080/87559129.2020.1733008 ↗
15. 10.1016/j.carbpol.2020.11732410.1016/j.carbpol.2020.117324 ↗
16. 10.1016/j.carbpol.2010.05.00110.1016/j.carbpol.2010.05.001 ↗
17. 10.1590/S1516-8913200500020001310.1590/S1516-89132005000200013 ↗
18. 10.1016/j.foodchem.2007.10.07810.1016/j.foodchem.2007.10.078 ↗
19. 10.1111/ijfs.1267810.1111/ijfs.12678 ↗
20. 10.4038/tar.v30i2.830410.4038/tar.v30i2.8304 ↗
21. 10.1016/j.foodhyd.2007.04.00210.1016/j.foodhyd.2007.04.002 ↗
22. 10.1016/j.foodhyd.2007.04.00310.1016/j.foodhyd.2007.04.003 ↗
23. 10.1016/j.foodhyd.2015.03.03010.1016/j.foodhyd.2015.03.030 ↗
24. 10.1111/1541-4337.1239410.1111/1541-4337.12394 ↗
25. 10.1016/j.ijbiomac.2021.06.08810.1016/j.ijbiomac.2021.06.088 ↗
26. 10.1016/j.bea.2021.10001810.1016/j.bea.2021.100018 ↗
27. Kulikouskaya V · J Biomed Mater Res A · 2019 · 107 · 181410.1002/jbm.a.36700 ↗
28. 10.1142/9789813140394_000110.1142/9789813140394_0001 ↗
29. Sousa RVRB · World J Pharm Pharm Sci · 2015 · 4 · 1571
30. 10.1039/c0fo00080a10.1039/c0fo00080a ↗
31. Ambuja SR · Int J Eng Res Appl · 2018 · 8 · 34
32. 10.1093/glycob/cwm05410.1093/glycob/cwm054 ↗
33. WHO. Cancer prevention, 2021. https://www.who.int/cancer/prevention/en/.
34. 10.1016/j.tifs.2011.11.00210.1016/j.tifs.2011.11.002 ↗
35. 10.1016/B978-0-12-817055-7.00010-810.1016/B978-0-12-817055-7.00010-8 ↗
36. 10.1016/j.carbpol.2015.09.06310.1016/j.carbpol.2015.09.063 ↗
37. 10.1016/j.ijbiomac.2020.08.13510.1016/j.ijbiomac.2020.08.135 ↗
38. 10.1089/jmf.2019.013610.1089/jmf.2019.0136 ↗
39. 10.1021/acs.jafc.8b0606310.1021/acs.jafc.8b06063 ↗
40. 10.1007/978-1-4020-6289-6_110.1007/978-1-4020-6289-6_1 ↗
41. 10.1016/j.biomaterials.2005.03.00510.1016/j.biomaterials.2005.03.005 ↗
42. 10.1016/j.jddst.2019.10149510.1016/j.jddst.2019.101495 ↗
43. 10.1016/j.ijbiomac.2017.05.16010.1016/j.ijbiomac.2017.05.160 ↗
44. 10.1021/acsomega.0c0613110.1021/acsomega.0c06131 ↗
45. 10.1021/la901389v10.1021/la901389v ↗
46. 10.1016/j.eurpolymj.2019.06.00110.1016/j.eurpolymj.2019.06.001 ↗
47. 10.1016/j.colsurfb.2014.12.05110.1016/j.colsurfb.2014.12.051 ↗
48. 10.1016/j.carbpol.2017.08.10710.1016/j.carbpol.2017.08.107 ↗
49. 10.1039/C5RA27865A10.1039/C5RA27865A ↗
50. 10.4103/0250-474X.16477010.4103/0250-474X.164770 ↗
51. 10.1080/09205063.2018.142381210.1080/09205063.2018.1423812 ↗
52. 10.1016/S0142-9612(00)00287-810.1016/S0142-9612(00)00287-8 ↗
53. 10.1021/acs.biomac.5b0042510.1021/acs.biomac.5b00425 ↗
54. 10.1039/C7NJ03973E10.1039/C7NJ03973E ↗
55. 10.1016/j.ijpharm.2016.04.00710.1016/j.ijpharm.2016.04.007 ↗
56. 10.1007/s12668-020-00752-y10.1007/s12668-020-00752-y ↗
57. 10.1016/j.carbpol.2011.09.06510.1016/j.carbpol.2011.09.065 ↗
58. 10.1016/j.carbpol.2011.03.03410.1016/j.carbpol.2011.03.034 ↗
59. 10.1016/j.msec.2019.10987310.1016/j.msec.2019.109873 ↗
60. 10.1021/acs.biomac.9b0133210.1021/acs.biomac.9b01332 ↗
61. 10.3390/ma1411310910.3390/ma14113109 ↗
62. 10.1016/j.carbpol.2019.05.02610.1016/j.carbpol.2019.05.026 ↗
63. 10.1002/adhm.20200117610.1002/adhm.202001176 ↗
64. 10.1016/j.carbpol.2017.05.03410.1016/j.carbpol.2017.05.034 ↗
65. 10.3390/ijms2107236410.3390/ijms21072364 ↗
66. 10.1002/app.3978810.1002/app.39788 ↗
67. 10.2147/tcrm.2006.2.4.33710.2147/tcrm.2006.2.4.337 ↗
68. 10.1016/j.carbpol.2016.10.06210.1016/j.carbpol.2016.10.062 ↗
69. Hannoodee M · 2022
70. 10.3390/pharmaceutics1203028510.3390/pharmaceutics12030285 ↗
71. 10.1038/nrc107410.1038/nrc1074 ↗
72. 10.1016/j.ejpb.2013.09.01710.1016/j.ejpb.2013.09.017 ↗
73. 10.1016/j.ejpb.2010.04.01310.1016/j.ejpb.2010.04.013 ↗
74. Mann SK · 2022
75. 10.1080/07373937.2018.154578310.1080/07373937.2018.1545783 ↗
76. Johnson DB · 2022
77. 10.1016/j.carbpol.2016.09.04810.1016/j.carbpol.2016.09.048 ↗
78. 10.4292/wjgpt.v6.i4.13710.4292/wjgpt.v6.i4.137 ↗
79. 10.1038/sj.pcan.450067910.1038/sj.pcan.4500679 ↗
80. Azémar M · Clin Med Oncol · 2007 · 1 · 73
81. 10.1200/JCO.2019.37.15_suppl.e1660910.1200/JCO.2019.37.15_suppl.e16609 ↗
82. 10.1002/ptr.195310.1002/ptr.1953 ↗
83. Zhao ZY · Altern Ther · 2008 · 14 · 34
84. Eliaz I · Altern Ther · 2019 · 25 · 20
85. 10.1016/j.vaccine.2014.03.02310.1016/j.vaccine.2014.03.023 ↗
86. 10.1016/j.eurpolymj.2019.05.02010.1016/j.eurpolymj.2019.05.020 ↗
87. 10.1039/C7BM00514H10.1039/C7BM00514H ↗
88. 10.1021/acsbiomaterials.9b0117810.1021/acsbiomaterials.9b01178 ↗
89. 10.1016/j.carbpol.2013.06.06710.1016/j.carbpol.2013.06.067 ↗
90. 10.1016/j.addr.2007.03.01210.1016/j.addr.2007.03.012 ↗
91. 10.1080/09205063.2012.69304710.1080/09205063.2012.693047 ↗
92. 10.1016/j.ijbiomac.2015.10.08710.1016/j.ijbiomac.2015.10.087 ↗
93. 10.1002/jbm.b.3407910.1002/jbm.b.34079 ↗
94. 10.1016/j.msec.2019.10997310.1016/j.msec.2019.109973 ↗
95. 10.1177/088532821561471310.1177/0885328215614713 ↗
96. 10.1016/j.ijbiomac.2010.10.00610.1016/j.ijbiomac.2010.10.006 ↗
97. 10.1016/j.ijbiomac.2014.11.03110.1016/j.ijbiomac.2014.11.031 ↗
98. 10.1039/C8MH00525G10.1039/C8MH00525G ↗
99. 10.1007/s12588-011-9016-y10.1007/s12588-011-9016-y ↗
100. 10.1515/polyeng-2019-037710.1515/polyeng-2019-0377 ↗